MRSA USA300 at Alaska native medical center, Anchorage, Alaska, USA, 2000-2006
dc.contributor.author | Zychowski, Diana L. | en |
dc.contributor.author | David, Michael Z. | en |
dc.contributor.author | Rudolph, Karen M. | en |
dc.contributor.author | Boyle-Vavra, Susan | en |
dc.contributor.author | Hennessy, Thomas W. | en |
dc.contributor.author | Asthi, Karthik | en |
dc.contributor.author | Daum, Robert S. | en |
dc.date.accessioned | 2018-03-02T16:29:22Z | en |
dc.date.available | 2018-03-02T16:29:22Z | en |
dc.date.issued | 2012-01 | en |
dc.description.abstract | To determine whether methicillin-resistant Staphylococcus aureus (MRSA) USA300 commonly caused infections among Alaska Natives, we examined clinical MRSA isolates from the Alaska Native Medical Center, Anchorage, during 2000–2006. Among Anchorage-region residents, USA300 was a minor constituent among MRSA isolates in 2000–2003 (11/68, 16%); by 2006, USA300 was the exclusive genotype identifi ed (10/10). | en |
dc.identifier.doi | https://doi.org/10.3201/eid1801.110746 | en |
dc.identifier.issue | 1 | en |
dc.identifier.uri | http://hdl.handle.net/10919/82436 | en |
dc.identifier.volume | 18 | en |
dc.language.iso | en | en |
dc.publisher | Centers for Disease Control and Prevention | en |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 United States | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | en |
dc.title | MRSA USA300 at Alaska native medical center, Anchorage, Alaska, USA, 2000-2006 | en |
dc.title.serial | Emerging Infectious Disease | en |
dc.type | Article | en |
dc.type.dcmitype | Text | en |